Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.650
+0.310 (7.14%)
Nov 4, 2024, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 29 employees as of December 31, 2023. The number of employees decreased by 7 or -19.44% compared to the previous year.
Employees
29
Change (1Y)
-7
Growth (1Y)
-19.44%
Revenue / Employee
$1,685,828
Profits / Employee
$94,310
Market Cap
127.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
23andMe Holding Co. | 582 |
Rockwell Medical | 237 |
908 Devices | 230 |
Pro-Dex | 148 |
Zomedica | 144 |
TriSalus Life Sciences | 112 |
PDS Biotechnology | 25 |
Annovis Bio | 16 |
FENC News
- 4 days ago - Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 7 days ago - Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Inc. (FENC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals Announces Management Change - GlobeNewsWire